Why is the sale of drugs with identical names for different ailments a concern for NHRC
NHRC has sought a report on the sale of drugs with similar names but used for different conditions.
The sale of drugs with identical names for different ailments is a concern for the NHRC (National Human Rights Commission) due to the following reasons:
- Misleading and confusing: When drugs with similar names are sold for different conditions, it can create confusion among patients and healthcare professionals. This can lead to medication errors, misdiagnosis, and wrong treatment.
- Potential harm to patients: If a patient mistakenly takes a drug intended for another condition, it may not only fail to provide the intended benefits but can also cause harmful side effects, worsening of symptoms, or even adverse reactions.
- Lack of informed consent: When patients are not aware of the differences in drugs bearing similar names, they might unknowingly consent to a treatment that is not suitable for their condition.
- Legal and ethical implications: Such practices may raise concerns about patient safety, medical negligence, and violation of the right to health. Patients have the right to receive accurate information and appropriate treatment for their specific ailments.
- Overall healthcare system integrity: Ensuring clear and distinct naming of drugs for different ailments is crucial for maintaining the integrity and trust in the healthcare system.
Answered
a year ago